Lviv clinical bulletin 2023, 1(41): 59-65

Criteria for Predicting Cardiovascular Events with Holter Electrocardiogram Monitoring (Literature Review and Results of own Research) in Patients with Heart Disease

V. Denesyuk, O. Barska, Yu. Shushkovska

National Pirogov Memorial Medical University, Vinnytsya

Introduction. This review is devoted to the current state of knowledge regarding the clinical value of Holter electrocardiogram monitoring to identify predictors of predicting future adverse cardiovascular events.

The aim of the study. Based on the study of modern sources and the results of own research, analyze scientific studies on the criteria for predicting cardiovascular events with Holter electrocardiogram monitoring in patients with heart disease.

Materials and methods. 52 sources of literature and the results of own research were analyzed, in which the role of Holter electrocardiogram monitoring in predicting adverse cardiovascular events was highlighted.

Results. The analysis of the literature and the results of our own research prove that the indisputable advantage of Holter electrocardiogram monitoring is the detection of prognostic and unfavorable indicators of the risk of sudden cardiac death, which, of course, is extremely important in modern society.

Conclusions. The high informativeness of Holter electrocardiogram monitoring for predicting future adverse cardiovascular events has been proven and the criteria for their prediction have been clarified.


  1. Barsʹka OV. Cardiovascular events and later remodeling of the heart and blood vessels after an acute coronary syndrome and increasing the effectiveness of preventive treatment. Vinnitsa: Edelʹveys i K; 2022. 216 р. (Ukrainian)
  2. Denesyuk VI, Moroz VM, Denesyuk OV. Arrhythmias and heart blocks: 30-year scientific and practical experience of studying heart rhythm disorders taking into account the recommendations of evidence-based medicine: a practical guide.Kyiv: DZK Center; 560 p.(Ukrainian)
  3. Denesyuk VI, Protsyuk RH, editors. Implementation of diagnostic, prognostic and treatment scales from internal medicine in the educational process of training students and doctors of postgraduate education: study guide. Kyiv: DZK Center; 168 p. (Ukrainian)
  4. Zharinov OY, Ivaniv YUA, Kutsʹ VO, Functional diagnostics: a textbook for intern doctors and trainee doctors of institutions (faculties) of postgraduate education of the Ministry of Health of Ukraine. 2nd ed., supplement. and processing. Kyiv: The Fourth Wave; 2021. 784 p. (Ukrainian)
  5. Zhdan VM, Katerenchuk ОІ. Circadian-related ectopic rhythms in young patients: ethiopathological features and principles of Actual Problems of the Modern Medicine: Bulletin of Ukrainian Medical Stomatological Academy. 2019;19(2):9-12. (Ukrainian)
  6. Ivanov VP, Shushkovska YuYu, Afanasiuk OI, Danylchuk AYe, Silina SM. Electrical myocardial instability as a problem of modern therapeutic practice – the realities of prognosis (a literature review). Zaporozhye Medical Journal. 2020;22(5):719-726. (Ukrainian)
  7. Kovalenko VM, Lutay MI, Sirenko YuM, Sychov OS, editors. Cardiovascular diseases. Classification, standards of diagnosis and treatment. Kyiv: Morion; 320 p. (Ukrainian)
  8. Kovalskyi PP, Kovalska TM. Prognostic value of determination turbulence and heart rhythm variability in patients with hypertension. Transport Medicine of Ukraine. 2015;3-4(55-56):20-23. (Ukrainian)
  9. Mostovoy YuM, Modern classifications and standards of treatment of diseases of internal organs. Emergency conditions in therapy. Analyzes. Normative indicators. Interpretation of changes. 24th ed., changes. and additional. Kyiv: DZK Center; 2018. 792 p. (Ukrainian)
  10. Recommendations of the working group on the violation of the rhythm of the heart of the Association of Cardiologists of Ukraine “Diagnosis and treatment of extrasystole and parasystole” [Internet]. [Cited 2013 Dec 19]; 28. р.). Available from: (Ukrainian)
  11. TashchukVK, IvanchukPR, HumeniukAL. Predictors of risk in patients with coronary and non-coronary heart diseases and ventricular extrasystoles, depending on heart rhythm turbulence. Clinical and Experimental Pathology. 2020;19(2):54-61.(Ukrainian)
  12. TashchukVK, Tashchuk MV, Ivanchuk PR. Digitalization of electrocardiography and photoplethysmography: clinical implementation of a quantity analysis of the heart rhytm. Сlinical and Experimental Pathology. 2019;18(2):80-85. (Ukrainian)
  13. Yabluchanskiy NI, Martynenko AV. Heart rate variability. Helping the practitioner [Internet]. Kharkov; [cited 2013 Dec 19]; 2010. 131). Available from: (Ukrainian)
  14. Arnar DO, Mairesse GH, Boriani G, Calkins H, Chin A, Coats A et al. ESC Scientific Document Group; EHRA Scientific Documents Committee. Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). 2019;21(6):844-845.
  15. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I et al. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol. 2008;52(17):1353-1365.
  16. Bigger JT Jr, Weld FM. Analysis of prognostic significance of ventricular arrhythmias after myocardial infarction. Shortcomings of Lown grading system. Br Heart J. 1981;45(6):717-724.
  17. Bikkina M, Larson MG, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol. 1993;22(4):1111-1116.
  18. Caussé C, Allaert FA, Marcantoni JP, Wolf JE. Fréquence et taux de dépistage de l’ischémie myocardique silencieuse en fonction de la durée du Holter chez les coronariens stables sous traitement. Etude sur 95,725 heures d’enregistrement [Frequency and detection rate of silent myocardial ischemia by Holter monitoring in patients with stable coronary insufficiency under treatment. Study of 95,725 recorded hours]. Arch Mal Coeur Vaiss. 2001;94(8):779-784.
  19. Chugh SS, Reinier K, Singh T, Uy-Evanado A, Socoteanu C, Peters D et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation. 2009;119(5):663-670.
  20. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation. 2003;108(10):1263-1277.
  21. Colivicchi F, Bassi A, Santini M, Caltagirone C. Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after acute ischemic stroke. Stroke. 2005;36(8):1710-1715.
  22. Conlon R, Tanner R, David S, Szeplaki G, Galvin J, Keaney J et al. Evaluation of the Tp-Te Interval, QTc and P-Wave Dispersion in Patients With Coronary Artery Ectasia. Cardiol Res. 2017;8(6):280-285.
  23. Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A Jr et al. ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). 1999;100(8):886-893.
  24. Cygankiewicz I. Heart rate turbulence. Prog Cardiovasc Dis. 2013;56(2):160-171.
  25. De Marchena E, Asch J, Martinez J, Wozniak P, Posada JD, Pittaluga J et al.  Usefulness of persistent silent myocardial ischemia in predicting a high cardiac event rate in men with medically controlled, stable angina pectoris. Am J Cardiol. 1994;73(5):390-392.
  26. De Maria B, Dalla Vecchia LA, Porta A, La Rovere MT. Autonomic dysfunction and heart rate variability with Holter monitoring: a diagnostic look at autonomic regulation. Herzschrittmacherther Elektrophysiol. 2021;32(3):315-319.
  27. Denesiuk VI, Denesiuk OV. The use of improved working clinical and prognostic classification of life-threatening arrhythmias and heart blocks in different cardiovascular diseases (reported and own findings). The Pharma Innovation. 2015;4(10):61-63.
  28. Frolov AV, Vaikhanskaya TG, Melnikova OP, Vorobiev AP, Guel LM. Risk stratification personalised model for prediction of life-threatening ventricular tachyarrhythmias in patients with chronic heart failure. Kardiol Pol. 2017;75(7):682-688.
  29. Gill JB, Cairns JA, Roberts RS, Costantini L, Sealey BJ, Fallen EF et al.  Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med. 1996;334(2):65-70.
  30. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med. 1986;314(19):1214-1219.
  31. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498.
  32. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59(4):256-262.
  33. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351(9101):478-484.
  34. La Rovere MT, Pinna GD, Maestri R, Barlera S, Bernardinangeli M, Veniani M et al. GISSI-HF Investigators. Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial. Eur J Heart Fail. 2012;14(12):1410-1419.
  35. Madjlessi-Simon T, Mary-Krause M, Fillette F, Lechat P, Jaillon P. Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J Am Coll Cardiol. 1996;27(7):1586-1591.
  36. Manyari DE. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;323(24):1706-1707.
  37. Marinheiro R, Parreira L, Amador P, Mesquita D, Farinha J, Fonseca M et al. Ventricular Arrhythmias in Patients with Obstructive Sleep Apnea. Curr Cardiol Rev. 2019;15(1):64-74.
  38. Moss TJ, Lake DE, Moorman JR. Local dynamics of heart rate: detection and prognostic implications. Physiol Meas. 2014;35(10):1929-1942.
  39. Nair CK, Khan IA, Esterbrooks DJ, Ryschon KL, Hilleman DE. Diagnostic and prognostic value of Holter-detected ST-segment deviation in unselected patients with chest pain referred for coronary angiography: a long-term follow-up analysis. 2001;120(3):834-839.
  40. Parreira L, Marinheiro R, Amador P, Mesquita D, Farinha J, Lopes A et al.  Frequent premature ventricular contractions. Association of burden and complexity with prognosis according to the presence of structural heart disease. Ann Noninvasive Electrocardiol. 2021;26(1):e12800.
  41. Patel DJ, Gomma AH, Knight CJ, Mulcahy DA, Wright CA, Purcell HJ et al.  Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina? An observational study of myocardial ischaemia and its relation to coronary anatomy. Eur Heart J. 2001;22(21):1991-199
  42. Pontone G, Guaricci AI, Andreini D, Solbiati A, Guglielmo M, Mushtaq S et al. Prognostic benefit of cardiac magnetic resonance over transthoracic echocardiography for the assessment of ischemic and nonischemic dilated cardiomyopathy patients referred for the evaluation of primary prevention implantable cardioverter-defibrillator therapy. Circ Cardiovasc Imaging. 2016;9(10):e004956.
  43. Rautaharju PM, Prineas RJ, Eifler WJ, Furberg CD, Neaton JD, Crow RS et al. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am Coll Cardiol. 1986;8(1):1-10.
  44. Rovio SP, Pahkala K, Nevalainen J, Juonala M, Salo P, Kähönen M et al.  Cardiovascular risk factors from childhood and midlife cognitive performance: the young finns study. J Am Coll Cardiol. 2017;69(18):2279-2289.
  45. Steinberg JS, Varma N, Cygankiewicz I, Aziz P, Balsam P, Baranchuk A et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Heart Rhythm. 2017;14(7):e55-e96.
  46. Sultana R, Sultana N, Rashid A, Rasheed SZ, Ahmed M, Ishaq M et al. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension. J Ayub Med Coll Abbottabad. 2010;22(4):155-15
  47. Vehmeijer JT, Koyak Z, Vink AS, Budts W, Harris L, Silversides CK et al. Prolonged Tpeak -Tend interval is a risk factor for sudden cardiac death in adults with congenital heart disease. Congenit Heart Dis. 2019;14(6):952-957.
  48. VytryhovskiyAI. Optimization of life-threatening ventricular ectopy and sudden cardiac death prevention in patients with postinfarction cardiosclerosis. Archive of Clinical Medicine. 2016;(22)2:15-18.
  49. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ et al. Detection of ischemia in asymptomatic diabetics investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27(8):1954-1961.
  50. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
  51. You T, Luo C, Zhang K, Zhang H. Electrophysiological Mechanisms Underlying T-Wave Alternans and Their Role in Arrhythmogenesis. Front Physiol. 2021;12:614946.
  52. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006;8(9):746-837.